In separate univariable survival analyses between MSS and microsatellite unstable CRC, TROP2 expression was only prognostically significant in MSS CRC (OS: p = 0.05, HR = 1.37; DSS: p = 0.014, HR = 1.58; DFS: p < 0.001, HR = 2.03, Figure 3), while no survival association was evident in microsatellite unstable cancers (OS, DSS, DFS: p > 0.05, respectively). The gene discussed is TACSTD2; the disease is cancer.